Catalyst PharmaceuticalsStock Price and Value Analysis

Should you buy Catalyst Pharmaceuticals stock? (NasdaqCM:CPRX). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantagesNeutral
None.
  • This company is not making money.
  • This company is less known than others.
  • This company has wild ups and downs.
  • This stock looks overpriced.
  • This company pays no dividend.

CPRX Free Cash Flow Trend

Hmm, we can't give any reliable projection for Catalyst Pharmaceuticals's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

Free Cash Flow trendline for CPRX
Free Cash Flow trendline for Catalyst Pharmaceuticals

Inside the CPRX Numbers

CPRX Price
(Catalyst Pharmaceuticals stock price per share)
$4.10
[?] PE Ratio versus Sector 100% lower than other Healthcare stocks
[?] PE Ratio versus Industry 100% lower than other Drugs - Generic stocks
[?] Cash Yield -4.28%
[?] Free Cash Flow Jitter 38%

Is Catalyst Pharmaceuticals Stock on Sale?

Based on our analysis, we believe that you should not buy Catalyst Pharmaceuticals right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy CPRX Stock?

Does Catalyst Pharmaceuticals have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.